مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

212
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

144
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

ANTI PNEUMOCOCCAL ACTIVITY OF AZITHROMYCIN-EUDRAGIT RS100 NANO- FORMULATIONS (SHORT COMMUNICATION)

Pages

  455-459

Abstract

 Propose: Bacterial pneumonia is a common lung infection caused by different types of bacteria. AZITHROMYCIN (AZI), an azalide antibiotic, is widely used to manage pneumococcal infections. Studies have shown that antibiotics in nanocarriers may lead to increased antibacterial activity and reduced toxicity. The aim of this work was to valuate in vitro antibacterial performance AZITHROMYCIN-Eudragit RS100 NANO-FORMULATIONs against Streptococcus pneumoniae and Staphylococcus aureus.Methods: AZI-Eudragit RS100 nanoparticles were prepared via electrospinning technique and the in vitro antibacterial performance against S. pneumoniae and S. aureus were assessed using agar dilution method.Results: Nanofibers in the sizes about 100-300 nm in diameter and micro scale in length and nanobeads in the range of 100-500 nm were achieved. The Minimum Inhibitory Concentrations (MIC) showed an enhancement in the antimicrobial effect of AZI-Eudragit RS100 nanofibers (40 mg/ml) compare to untreated AZI solution (>160 mg/ml) against S. pneumonia. The MIC value for AZI-Eudragit RS100 nanofibers against S. aureus was>128 mg/ml, same as that of the untreated AZI solution.Conclusion: The enhanced efficiency of AZI in nanofibers could be related to the more adsorption opportunity of nanofibers to S. pneumonia capsulated cell wall which provides an antibiotic depot on the bacterial surface compared to S. aureus. AZI-Eudragit RS100 nanofibers with enhanced antimicrobial effect against S. pneumonia can be considered as a candidate for in vivo evaluations in antibiotic therapy of Pneumococcal infections.

Cites

  • No record.

    • References

  • No record.

    • Cite

    APA: Copy

    ADIBKIA, KHOSRO, KHORASANI, GOLROKH, PAYAB, SHAHRIAR, & LOTFIPOUR, FARZANEH. (2016). ANTI PNEUMOCOCCAL ACTIVITY OF AZITHROMYCIN-EUDRAGIT RS100 NANO- FORMULATIONS (SHORT COMMUNICATION). ADVANCED PHARMACEUTICAL BULLETIN, 6(3), 455-459. SID. https://sid.ir/paper/331837/en

    Vancouver: Copy

    ADIBKIA KHOSRO, KHORASANI GOLROKH, PAYAB SHAHRIAR, LOTFIPOUR FARZANEH. ANTI PNEUMOCOCCAL ACTIVITY OF AZITHROMYCIN-EUDRAGIT RS100 NANO- FORMULATIONS (SHORT COMMUNICATION). ADVANCED PHARMACEUTICAL BULLETIN[Internet]. 2016;6(3):455-459. Available from: https://sid.ir/paper/331837/en

    IEEE: Copy

    KHOSRO ADIBKIA, GOLROKH KHORASANI, SHAHRIAR PAYAB, and FARZANEH LOTFIPOUR, “ANTI PNEUMOCOCCAL ACTIVITY OF AZITHROMYCIN-EUDRAGIT RS100 NANO- FORMULATIONS (SHORT COMMUNICATION),” ADVANCED PHARMACEUTICAL BULLETIN, vol. 6, no. 3, pp. 455–459, 2016, [Online]. Available: https://sid.ir/paper/331837/en

    Related Journal Papers

  • No record.

    • Related Seminar Papers

  • No record.

    • Related Plans

  • No record.

    • Recommended Workshops






    Move to top
    telegram sharing button
    whatsapp sharing button
    linkedin sharing button
    twitter sharing button
    email sharing button
    email sharing button
    email sharing button
    sharethis sharing button